Medite Cancer Diagnostics, Inc.

OTCPK:MDIT Stock Report

Market Cap: US$8.6k

Medite Cancer Diagnostics Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure6.2yrs

Recent management updates

No updates

Recent updates

No updates


CEO

Medite Cancer Diagnostics has no CEO, or we have no data on them.


Board Members

NamePositionTenureCompensationOwnership
John Abeles
Independent Director24.7yrsUS$123.88kno data
Joel Kanter
Independent Director6.2yrsno datano data
Gregory Fortunoff
Director6yrsno datano data
William Lewis
Independent Chairman of Boardno dataUS$168.66kno data

6.2yrs

Average Tenure

59.5yo

Average Age

Experienced Board: MDIT's board of directors are considered experienced (6.2 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.